US Congressman Attempts to Sway DEA From Rescheduling Cannabis
Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule....
"It's a great update on national news."
Ruth Aguiar
Founder/COO CannabiSalud